Anupam Rasayan to Acquire Jayhawk Fine Chemicals for ~$150M
Anupam Rasayan to acquire Jayhawk Fine Chemicals for ~$150M (₹1,249.65 crore), expanding its US presence and diversifying into high-value markets. The acquisition will be funded through internal accruals, debt and equity.
The acquisition represents a significant strategic move for Anupam Rasayan, expanding its presence in the U.S. and diversifying its product portfolio. The deal is worth a significant amount.
The acquisition is expected to provide Anupam Rasayan with access to new chemistries, a global customer base, and a U.S.-based platform for CDMO expansion. Also, Jayhawk is profitable with good revenue.
* Anupam Rasayan India Limited has signed a definitive agreement to acquire 100% equity in Jayhawk Fine Chemicals LLC, a U.S.-based specialty chemicals company. * The enterprise value of the acquisition is approximately ~$134 million (₹1,116.68 crore), with a total purchase consideration of ~$150 million (₹1,249.65 crore), including ~$16 million (₹133.29 crore) of cash and cash equivalents on Jayhawk’s balance sheet. * The acquisition will be funded through a combination of internal accruals, debt, and quasi equity. * Jayhawk manufactures performance materials (~65%) and life/crop science molecules (~35%). * Jayhawk has revenue of ~$78 million (₹649.82 crore) and EBITDA of ~$15 million (₹124.97 crore) in 2024. * The acquisition provides Anupam with access to new chemistries, a global customer base, and a U.S.-based platform for CDMO expansion. * A global investment management firm will co-fund the acquisition. * Anupam acquired ~26% stake in Tanfac for ~₹1,530M in May’22 at market cap of ₹5,950 M.
What to do with a filing like this
Anupam Rasayan India Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Anupam Rasayan India Limited. Read the original for the full detail.